Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-14

Clinical Trial Update: Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia [Phase 3]

View source ↗

Summary

A phase 3, placebo-controlled trial evaluating Botulinum Toxin A for provoked vestibulodynia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Karolinska Institutet | Conditions: Vulvodynia | Phase 3 | Status: COMPLETED